GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...
Professor Popper is an expert in international economics and finance. She is the incoming 2020 Emerging Ethics Scholar at the Markkula Center for Applied Ethics; she is a Fellow of the Asian Bureau of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results